Cargando…
Expression of Serum sLOX-1 in Patients with Non-Small-Cell Lung Cancer and Its Correlation with Lipid Metabolism
OBJECTIVE: The aim of this study was to investigate the expression level of soluble LOX-1 (sLOX-1) in the serum of non-small-cell lung cancer (NSCLC) patients and its correlation with lipid metabolism. METHODS: 99 inpatients with NSCLC and 81 healthy controls were enrolled in this study. The levels...
Autores principales: | Hao, Fangfang, Chen, Jinliang, Wu, Jinnan, Ge, Xin, Lv, Xuedong, Zhang, Dongmei, Chen, Jianrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017481/ https://www.ncbi.nlm.nih.gov/pubmed/35449557 http://dx.doi.org/10.1155/2022/6619331 |
Ejemplares similares
-
sLOX-1: A Molecule for Evaluating the Prognosis of Recurrent Ischemic Stroke
por: Zheng, Yangmin, et al.
Publicado: (2021) -
Correlation of sLOX-1 Levels and MR Characteristics of Culprit Plaques in Intracranial Arteries with Stroke Recurrence
por: Ren, Kaixuan, et al.
Publicado: (2023) -
Clinical Value of Serum and Exhaled Breath Condensate miR-186 and
IL-1β Levels in Non-Small Cell Lung Cancer
por: Xie, Haiqin, et al.
Publicado: (2020) -
Association of the LOX-1 rs1050283 Polymorphism with Risk for Atherosclerotic Cerebral Infarction and its Effect on sLOX-1 and LOX-1 Expression in a Chinese Population
por: Guo, Xin, et al.
Publicado: (2017) -
Role of sLOX‐1 in intracranial artery stenosis and in predicting long‐term prognosis of acute ischemic stroke
por: Li, Xian‐Mei, et al.
Publicado: (2017)